NCT01796197 2026-02-05
Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa
Dana-Farber Cancer Institute
Phase 2 Completed
Clinical Trials
4 trialsNCT00210236 2025-10-20
AXIL95
Institut Bergonié
Phase 3 Terminated
NCT02883062 2025-10-16
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT01841749 2025-09-12
CINNAMOME
Institut Bergonié
Completed